Albert Einstein College of Medicine

Follow-Up – Fall 2017

Research doesn’t stop when we report it. Here are updates on past UConn Health Journal stories:


UConn Center on Aging

The UConn Center on Aging is one of 14 planned study sites for the TAME (Targeting Aging with Metformin) clinical trial led by Albert Einstein College of Medicine’s Dr. Nir Barzilai and colleagues from Wake Forest School of Medicine. The researchers hope to test the ability of diabetes drug metformin to slow development of aging-related conditions such as cancer, dementia, and cardiovascular diseases.

the Flu

Spring 2017, “Aches, Age, and Influenza”


Childhood Anxiety Research

Anxiety in children may need to be treated as a chronic condition that requires regular follow-up, reported UConn Health psychologist Golda Ginsburg at this year’s Anxiety and Depression Association of America conference. The results are from a study that followed 488 children and adolescents with anxiety who were randomly assigned to get cognitive behavioral therapy (CBT), an antidepressant, CBT and an antidepressant, or a placebo. Remission rates five years after treatment were the same, no matter the treatment.

Russian nesting dolls illustrating the pattern of anxiety

Winter 2015, “Breaking the Cycle: How Anxious Parents Can Protect Their Kids from Becoming Anxious Adults